277 related articles for article (PubMed ID: 23876321)
1. Transitioning from genotypes to epigenotypes: why the time has come for medulloblastoma epigenomics.
Batora NV; Sturm D; Jones DT; Kool M; Pfister SM; Northcott PA
Neuroscience; 2014 Apr; 264():171-85. PubMed ID: 23876321
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic Drivers in Pediatric Medulloblastoma.
Roussel MF; Stripay JL
Cerebellum; 2018 Feb; 17(1):28-36. PubMed ID: 29178021
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic regulation in medulloblastoma.
Yi J; Wu J
Mol Cell Neurosci; 2018 Mar; 87():65-76. PubMed ID: 29269116
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic deregulation of multiple S100 gene family members by differential hypomethylation and hypermethylation events in medulloblastoma.
Lindsey JC; Lusher ME; Anderton JA; Gilbertson RJ; Ellison DW; Clifford SC
Br J Cancer; 2007 Jul; 97(2):267-74. PubMed ID: 17579622
[TBL] [Abstract][Full Text] [Related]
5. Medulloblastoma epigenetics and the path to clinical innovation.
Haltom AR; Toll SA; Cheng D; Maegawa S; Gopalakrishnan V; Khatua S
J Neurooncol; 2020 Oct; 150(1):35-46. PubMed ID: 32816225
[TBL] [Abstract][Full Text] [Related]
6. Medulloblastoma molecular dissection: the way toward targeted therapy.
Remke M; Ramaswamy V; Taylor MD
Curr Opin Oncol; 2013 Nov; 25(6):674-81. PubMed ID: 24076581
[TBL] [Abstract][Full Text] [Related]
7. FISH and chips: the recipe for improved prognostication and outcomes for children with medulloblastoma.
Ramaswamy V; Northcott PA; Taylor MD
Cancer Genet; 2011 Nov; 204(11):577-88. PubMed ID: 22200083
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic regulation in medulloblastoma pathogenesis revealed by genetically engineered mouse models.
Shiraishi R; Kawauchi D
Cancer Sci; 2021 Aug; 112(8):2948-2957. PubMed ID: 34050694
[TBL] [Abstract][Full Text] [Related]
9. A Novel Method for Rapid Molecular Subgrouping of Medulloblastoma.
Gómez S; Garrido-Garcia A; Garcia-Gerique L; Lemos I; Suñol M; de Torres C; Kulis M; Pérez-Jaume S; Carcaboso ÁM; Luu B; Kieran MW; Jabado N; Kozlenkov A; Dracheva S; Ramaswamy V; Hovestadt V; Johann P; Jones DTW; Pfister SM; Morales La Madrid A; Cruz O; Taylor MD; Martin-Subero JI; Mora J; Lavarino C
Clin Cancer Res; 2018 Mar; 24(6):1355-1363. PubMed ID: 29351917
[No Abstract] [Full Text] [Related]
10. Epigenetic events in medulloblastoma development.
Lindsey JC; Anderton JA; Lusher ME; Clifford SC
Neurosurg Focus; 2005 Nov; 19(5):E10. PubMed ID: 16398460
[TBL] [Abstract][Full Text] [Related]
11. Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencing.
Hovestadt V; Jones DT; Picelli S; Wang W; Kool M; Northcott PA; Sultan M; Stachurski K; Ryzhova M; Warnatz HJ; Ralser M; Brun S; Bunt J; Jäger N; Kleinheinz K; Erkek S; Weber UD; Bartholomae CC; von Kalle C; Lawerenz C; Eils J; Koster J; Versteeg R; Milde T; Witt O; Schmidt S; Wolf S; Pietsch T; Rutkowski S; Scheurlen W; Taylor MD; Brors B; Felsberg J; Reifenberger G; Borkhardt A; Lehrach H; Wechsler-Reya RJ; Eils R; Yaspo ML; Landgraf P; Korshunov A; Zapatka M; Radlwimmer B; Pfister SM; Lichter P
Nature; 2014 Jun; 510(7506):537-41. PubMed ID: 24847876
[TBL] [Abstract][Full Text] [Related]
12. A molecular fingerprint for medulloblastoma.
Lee Y; Miller HL; Jensen P; Hernan R; Connelly M; Wetmore C; Zindy F; Roussel MF; Curran T; Gilbertson RJ; McKinnon PJ
Cancer Res; 2003 Sep; 63(17):5428-37. PubMed ID: 14500378
[TBL] [Abstract][Full Text] [Related]
13. Medulloblastoma harbor somatic mitochondrial DNA mutations in the D-loop region.
Lueth M; von Deimling A; Pietsch T; Wong LJ; Kurtz A; Henze G; Driever PH
J Pediatr Hematol Oncol; 2010 Mar; 32(2):156-9. PubMed ID: 20147852
[TBL] [Abstract][Full Text] [Related]
14. Array-based profiling of reference-independent methylation status (aPRIMES) identifies frequent promoter methylation and consecutive downregulation of ZIC2 in pediatric medulloblastoma.
Pfister S; Schlaeger C; Mendrzyk F; Wittmann A; Benner A; Kulozik A; Scheurlen W; Radlwimmer B; Lichter P
Nucleic Acids Res; 2007; 35(7):e51. PubMed ID: 17344319
[TBL] [Abstract][Full Text] [Related]
15. Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations.
Thompson MC; Fuller C; Hogg TL; Dalton J; Finkelstein D; Lau CC; Chintagumpala M; Adesina A; Ashley DM; Kellie SJ; Taylor MD; Curran T; Gajjar A; Gilbertson RJ
J Clin Oncol; 2006 Apr; 24(12):1924-31. PubMed ID: 16567768
[TBL] [Abstract][Full Text] [Related]
16. Medulloblastoma biology in the post-genomic era.
Archer TC; Pomeroy SL
Future Oncol; 2012 Dec; 8(12):1597-604. PubMed ID: 23231521
[TBL] [Abstract][Full Text] [Related]
17. The epigenetics of brain tumors.
Dubuc AM; Mack S; Unterberger A; Northcott PA; Taylor MD
Methods Mol Biol; 2012; 863():139-53. PubMed ID: 22359291
[TBL] [Abstract][Full Text] [Related]
18. Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma.
Kumar R; Smith KS; Deng M; Terhune C; Robinson GW; Orr BA; Liu APY; Lin T; Billups CA; Chintagumpala M; Bowers DC; Hassall TE; Hansford JR; Khuong-Quang DA; Crawford JR; Bendel AE; Gururangan S; Schroeder K; Bouffet E; Bartels U; Fisher MJ; Cohn R; Partap S; Kellie SJ; McCowage G; Paulino AC; Rutkowski S; Fleischhack G; Dhall G; Klesse LJ; Leary S; Nazarian J; Kool M; Wesseling P; Ryzhova M; Zheludkova O; Golanov AV; McLendon RE; Packer RJ; Dunham C; Hukin J; Fouladi M; Faria CC; Pimentel J; Walter AW; Jabado N; Cho YJ; Perreault S; Croul SE; Zapotocky M; Hawkins C; Tabori U; Taylor MD; Pfister SM; Klimo P; Boop FA; Ellison DW; Merchant TE; Onar-Thomas A; Korshunov A; Jones DTW; Gajjar A; Ramaswamy V; Northcott PA
J Clin Oncol; 2021 Mar; 39(7):807-821. PubMed ID: 33502920
[TBL] [Abstract][Full Text] [Related]
19. Combined genome-wide allelotyping and copy number analysis identify frequent genetic losses without copy number reduction in medulloblastoma.
Langdon JA; Lamont JM; Scott DK; Dyer S; Prebble E; Bown N; Grundy RG; Ellison DW; Clifford SC
Genes Chromosomes Cancer; 2006 Jan; 45(1):47-60. PubMed ID: 16149064
[TBL] [Abstract][Full Text] [Related]
20. Medulloblastomics: the end of the beginning.
Northcott PA; Jones DT; Kool M; Robinson GW; Gilbertson RJ; Cho YJ; Pomeroy SL; Korshunov A; Lichter P; Taylor MD; Pfister SM
Nat Rev Cancer; 2012 Dec; 12(12):818-34. PubMed ID: 23175120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
